• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮祖细胞有助于加速肝脏再生。

Endothelial progenitor cells contribute to accelerated liver regeneration.

作者信息

Beaudry Paul, Hida Yasuhiro, Udagawa Taturo, Alwayn Ian P, Greene Arin K, Arsenault Danielle, Folkman Judah, Heymach John V, Ryeom Sandra, Puder Mark

机构信息

Vascular Biology Program, Department of Surgery, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

出版信息

J Pediatr Surg. 2007 Jul;42(7):1190-8. doi: 10.1016/j.jpedsurg.2007.02.034.

DOI:10.1016/j.jpedsurg.2007.02.034
PMID:17618879
Abstract

Two classes of circulating endothelial cells (CECs) have been identified and are distinguished by the expression of the stem cell markers CD117 or CD133 together with endothelial-specific antigens. Stem cell marker-positive CECs originate from bone marrow and have been designated as circulating endothelial progenitors (CEPs). We have demonstrated that exogenous vascular endothelial growth factor (VEGF) effectively mobilizes CEP cells. Furthermore, it has been demonstrated that VEGF regulates liver regeneration after partial hepatectomy. Although local endothelial cells can regulate tissue mass during liver regeneration, the contribution of CEPs to this process is unknown. We discovered loss of CD117 and CD133 from murine CEP cells and that both markers underestimated the number of bone marrow-derived CEP cells. We therefore used wild type and green fluorescent protein (GFP)-bone marrow transplanted into wild-type mice and performed 70% hepatectomies. Furthermore, we found that treatment with exogenous VEGF accelerated liver regeneration after 70% hepatectomy, whereas immunohistochemical analysis showed a 7-fold increase in the incorporation of CEP cells into liver vasculature. These results suggest that CEP cells play a role in regulating liver regeneration and that VEGF treatment can mobilize CEP cells to accelerate this process.

摘要

已识别出两类循环内皮细胞(CEC),它们通过干细胞标志物CD117或CD133与内皮特异性抗原的表达来区分。干细胞标志物阳性的CEC起源于骨髓,被指定为循环内皮祖细胞(CEP)。我们已经证明,外源性血管内皮生长因子(VEGF)能有效动员CEP细胞。此外,已经证明VEGF可调节部分肝切除术后的肝脏再生。虽然局部内皮细胞在肝脏再生过程中可调节组织质量,但CEP对这一过程的贡献尚不清楚。我们发现小鼠CEP细胞中CD117和CD133缺失,且这两种标志物均低估了骨髓来源的CEP细胞数量。因此,我们将野生型和绿色荧光蛋白(GFP)骨髓移植到野生型小鼠体内,并进行了70%肝切除术。此外,我们发现外源性VEGF治疗可加速70%肝切除术后的肝脏再生,而免疫组织化学分析显示CEP细胞整合到肝脏血管系统中的数量增加了7倍。这些结果表明,CEP细胞在调节肝脏再生中发挥作用,VEGF治疗可动员CEP细胞加速这一过程。

相似文献

1
Endothelial progenitor cells contribute to accelerated liver regeneration.内皮祖细胞有助于加速肝脏再生。
J Pediatr Surg. 2007 Jul;42(7):1190-8. doi: 10.1016/j.jpedsurg.2007.02.034.
2
Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice.小鼠部分肝切除术后骨髓细胞对肝脏再生的贡献。
J Hepatol. 2002 May;36(5):653-9. doi: 10.1016/s0168-8278(02)00043-0.
3
Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair.人胚干细胞源性 CD133+内皮祖细胞移植治疗性血管生成修复心肌。
Regen Med. 2010 Mar;5(2):231-44. doi: 10.2217/rme.09.83.
4
Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis.骨折愈合和牵张成骨过程中内皮祖细胞的动员
Bone. 2008 May;42(5):932-41. doi: 10.1016/j.bone.2008.01.007. Epub 2008 Jan 26.
5
Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity.血管内皮生长因子受体-2抑制剂ZD6474对循环内皮祖细胞和成熟循环内皮细胞的不同作用:对用作抗血管生成活性替代标志物的意义
Clin Cancer Res. 2005 May 1;11(9):3514-22. doi: 10.1158/1078-0432.CCR-04-2271.
6
Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells.通过局部注射人外周血来源的CD133阳性细胞加速大鼠骨骼肌损伤模型中的骨骼肌再生。
Stem Cells. 2009 Apr;27(4):949-60. doi: 10.1002/stem.4.
7
Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration.自体CD133+骨髓细胞经门静脉应用于肝脏:支持肝再生的新概念。
Stem Cells. 2005 Apr;23(4):463-70. doi: 10.1634/stemcells.2004-0283.
8
Reduced number of circulating endothelial progenitor cells (CD133+/KDR+) in patients with plaque psoriasis.斑块状银屑病患者循环内皮祖细胞(CD133+/KDR+)数量减少。
Dermatology. 2012;225(1):88-92. doi: 10.1159/000341534. Epub 2012 Sep 11.
9
Measuring angiogenic cytokines, circulating endothelial cells, and endothelial progenitor cells in peripheral blood and cord blood: VEGF and CXCL12 correlate with the number of circulating endothelial progenitor cells in peripheral blood.测量外周血和脐带血中的血管生成细胞因子、循环内皮细胞和内皮祖细胞:血管内皮生长因子(VEGF)和CXC趋化因子配体12(CXCL12)与外周血中循环内皮祖细胞的数量相关。
Tissue Eng Part C Methods. 2008 Mar;14(1):59-67. doi: 10.1089/tec.2007.0251.
10
Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.内皮祖细胞并非来源于CD133+细胞或CD45+造血前体细胞。
Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1572-9. doi: 10.1161/ATVBAHA.107.144972. Epub 2007 May 10.

引用本文的文献

1
Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies.血管肉瘤:关于诊断、预后及治疗策略中生物标志物的系统综述
Front Oncol. 2025 Jul 1;15:1623327. doi: 10.3389/fonc.2025.1623327. eCollection 2025.
2
In situ Reprogramming as a Pro-Angiogenic Inducer to Rescue Ischemic Tissues.原位重编程作为一种促血管生成诱导剂用于挽救缺血组织。
Pulse (Basel). 2024 May 29;12(1):58-65. doi: 10.1159/000538075. eCollection 2024 Jan-Dec.
3
Stem cell therapy and tissue engineering strategies using cell aggregates and decellularized scaffolds for the rescue of liver failure.
使用细胞聚集体和脱细胞支架的干细胞疗法及组织工程策略用于挽救肝衰竭。
J Tissue Eng. 2021 Feb 1;12:2041731420986711. doi: 10.1177/2041731420986711. eCollection 2021 Jan-Dec.
4
Current and Emerging Approaches for Hepatic Fibrosis Treatment.肝纤维化治疗的当前及新出现的方法
Gastroenterol Res Pract. 2021 Jul 16;2021:6612892. doi: 10.1155/2021/6612892. eCollection 2021.
5
C-Kit, a Double-Edged Sword in Liver Regeneration and Diseases.C-Kit:肝脏再生与疾病中的双刃剑
Front Genet. 2021 Feb 2;12:598855. doi: 10.3389/fgene.2021.598855. eCollection 2021.
6
Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview.细胞治疗肝纤维化的作用机制:概述。
Cells. 2019 Oct 29;8(11):1339. doi: 10.3390/cells8111339.
7
Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis.基于干细胞的肝硬化学治疗的当前观点。
Can J Gastroenterol Hepatol. 2018 Jan 29;2018:4197857. doi: 10.1155/2018/4197857. eCollection 2018.
8
Endothelial Progenitor Cells Physiology and Metabolic Plasticity in Brain Angiogenesis and Blood-Brain Barrier Modeling.内皮祖细胞在脑微血管生成和血脑屏障建模中的生理学及代谢可塑性
Front Physiol. 2016 Dec 1;7:599. doi: 10.3389/fphys.2016.00599. eCollection 2016.
9
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.胎盘生长因子及其在糖尿病视网膜病变和其他眼部新生血管疾病中的潜在作用。
Acta Ophthalmol. 2018 Feb;96(1):e1-e9. doi: 10.1111/aos.13325. Epub 2016 Nov 22.
10
Management of Liver Failure: From Transplantation to Cell-Based Therapy.肝衰竭的管理:从移植到基于细胞的治疗。
Cell Med. 2011 Jun 1;2(1):9-25. doi: 10.3727/215517911X575993. eCollection 2011.